CTOs on the Move

Alcami

www.alcami.com

 
Alcami is a contract development and manufacturing organization headquartered in North Carolina with over 40 years of experience advancing products through every stage of the development lifecycle. Alcami serves pharmaceutical and biotech companies of all sizes for small molecules and biologics, providing customizable and innovative solutions for analytical development, clinical to commercial sterile and oral solid dose drug product manufacturing, packaging, microbiology, cGMP biostorage, environmental monitoring, and pharmaceutical support services. Alcami`s private equity ownership includes GHO Capital, The Vistria Group, and Ampersand Capital Partners.
  • Number of Employees: 250-1000
  • Annual Revenue: $250-500 Million
  • www.alcami.com
  • 2320 Scientific Park Drive
    Wilmington, NC USA 28405
  • Phone: 910.254.7000

Executives

Name Title Contact Details
Tariq Jamal
 Chief Information Officer Profile

Similar Companies

Cephazone Pharma

Cephazone Pharma is a Pomona, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Memphis Chemical and Janitorial Supply De(3B's)

Memphis Chemical and Janitorial Supply De(3B's LLC) is a Memphis, TN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

AMGIT

AMGIT is a San Antonio, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Innodia

Innodia Inc. is a Laval, QC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Shire

At Shire, we enable people with life altering conditions to lead better lives. We focus on developing and delivering innovative treatments for patients with rare diseases and other specialty conditions.To realize our aspiration to become a leading global biotech, our efforts are concentrated on four key strategic drivers: growth, innovation, efficiency, and people. Our priorities are to drive optimal performance of our existing products, increase patient access to these medicines, and to build our pipeline through research and development and partnerships in order to deliver new medicines to patients.